GUIDELINES   Free access

Giornale Italiano di Dermatologia e Venereologia 2019 April;154(2):99-105

DOI: 10.23736/S0392-0488.18.06223-5

Copyright © 2018 EDIZIONI MINERVA MEDICA

lingua: Inglese

Tuscan consensus on the use of UVBnb phototherapy in the treatment of psoriasis

Filomena RUSSO ¹ ✉, Martina VISPI ², Riccardo SIRNA ², Virginia MANCINI ³, Giovanni BAGNONI ⁴, Laura BARTOLI ⁵, Mauro BELLINI ⁶, Luca BRANDINI ⁷, Marzia CAPRONI ⁸, Antonio CASTELLI ⁹, Roberto CECCHI ⁵, Aldo CUCCIA ⁹, Michele FIMIANI ¹, Marta GRAZZINI ¹⁰, Franco MARSILI ¹¹, Carlo MAZZATENTA ¹⁰, Maria C. NICCOLI ¹², Salvatore PANDURI ¹³, Camilla PECCIANTI ², Silvia PECENCO ⁴, Nicola PIMPINELLI ¹⁴, Francesca PRIGNANO ¹⁴, Federica RICCERI ¹⁴, Marco ROMANELLI ¹³, Susanna ROSSARI ¹¹, Franca TAVITI ¹², Walter VOLPI ⁸, Michele PELLEGRINO ¹

¹ Section of Dermatology, Department of Clinical Medicine and Immunological Science, University of Siena, Siena, Italy; ² Section of Dermatology, Department of Dermatology, Misericordia Hospital, Grosseto, Italy; ³ Section of Pathology, Department of Medical Biotechnology, University of Siena, Siena, Italy; ⁴ Unit of Dermatology, Livorno Hospital, Livorno, Italy; ⁵ Unit of Dermatology, San Jacopo Hospital, Pistoia, Italy; ⁶ Unit of Dermatology, Carrara Hospital, Carrara, Italy; ⁷ Unit of Dermatology, San Giuseppe Hospital, Empoli, Italy; ⁸ Unit of Dermatologic Rare Disease and Skin Immunopathology, Department of Dermatology, University of Florence, Florence, Italy; ⁹ Unit of Dermatology, San Donato Hospital, Arezzo, Italy; ¹⁰ Unit of Dermatology, Campo di Marte Hospital, Lucca, Italy; ¹¹ Unit of Dermatology, Versilia Hospital, Lido di Camaiore, Lucca, Italy; ¹² Unit of Dermatology, Prato Hospital, Prato, Italy; ¹³ Department of Dermatology, University of Pisa, Pisa, Italy; ¹⁴ Department of Surgery and Translational Medicine, Dermatology Clinic, University of Florence, Florence, Italy

Psoriasis (PSO) is traditionally defined as an immune-mediated, inflammatory dermatological disease characterized by a chronic-relapsing course and associated with multifactorial inheritance (genetic predisposition and influence of various environmental factors). Considered until recently a dermatological disease only, today PSO is correctly known as a systemic one because of the involvement of multiple organs with important impact on social life and relationships. PSO is found in the 0.3-4.6% of the world’s population, while its prevalence in the Italian population is estimated at 2.8%. Therefore, if we consider that in Tuscany more than 100,000 people out of 3,672,202 suffer of psoriasis, it is of paramount importance to focus on a shared clinical and therapeutic protocol to manage the disease. With the aim of ensuring diagnostic-therapeutic suitability, high levels of care and standardization of treatment, a unique clinical-therapeutic management model has been developed and validated in Tuscany, involving all accredited regional dermatological centers. Among the possible alternatives to be implemented in the treatment of patients with mild, moderate-severe psoriasis, UVBnb phototherapy is widely used alone or in association with other systemic and non-systemic devices. Despite this, there is still no universally shared therapeutic protocol. In this context the CO.FO.TO working group (Consensus Fototerapia Toscana) is born with the aim of defining and validating the main guidelines in the use of phototherapy with UVBnb in psoriasis; the guidelines are based both on the real-life experience of the different centers of reference in the region and on the revision of the recent literature.

KEY WORDS: Psoriasis - Phototherapy - Narrow band imaging - Administration, topical